TV Schedule

Controversial cholesterol drug Vytorin patients more likely to develop cancer.

  2. CarolynGillis
  3. related topics
Vytorin, the controversial cholesterol drug sold by Merck and Schering-Plough, failed to meet the main goal in another important study. What’s worse, the study also found that patients taking Vytorin in the study were more likely to develop cancer.

http://www.askapatient.com/viewratings.asp?drug=21687&a...
CarolynGillis

Add your response

Login/Registration is required to add a response.